Ernest Oncology | Sunitinib 50mg Sunisam Capsules Exporter to UAE & Gulf

Sunisam 50mg Capsules (Sunitinib): Global Procurement & Clinical Guide

In the advanced treatment of solid tumors, Sunisam 50mg Capsules (containing Sunitinib) have become a vital therapeutic option for patients worldwide. As a leading pharmaceutical exporter from India, Ernest Oncology (a group of Ernest Pharmaceutical Pvt. Ltd.) specializes in the bulk supply and global distribution of this critical oncology medication to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa.

This comprehensive guide provides deep clinical insights into Sunisam 50mg and the advantages of sourcing through a verified Indian exporter.

What is Sunisam 50mg?

Sunisam 50 mg is an oral multi-targeted receptor tyrosine kinase (RTK) inhibitor. The active ingredient, Sunitinib, is designed to target specific pathways that allow cancer cells to grow, survive, and spread. The 50 mg strength is frequently utilized as the standard starting dose for several aggressive malignancies due to its high-potency profile.

Key Therapeutic Indications

Sunisam 50 mg is globally recognized for the treatment of:

• Advanced Renal Cell Carcinoma (RCC): The primary systemic therapy for metastatic kidney cancer.

• Gastrointestinal Stromal Tumors (GIST): For patients who are resistant to or cannot tolerate Imatinib.

• Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors in the pancreas.

Clinical Mechanism and Efficacy

Sunisam functions through a sophisticated dual inhibitory mechanism:

1. Anti-Angiogenesis: It blocks the VEGFR (Vascular Endothelial Growth Factor Receptor) pathways, effectively cutting off the blood and nutrient supply that tumors need to grow.

2. Anti-Proliferation: It inhibits PDGFR (Platelet-Derived Growth Factor Receptor) and KIT receptors, which stops the internal signaling that tells cancer cells to multiply.

For healthcare providers in London and the USA, Sunisam is trusted for its ability to significantly improve progression-free survival (PFS) in patients with advanced solid tumors

Why Source Sunisam 50 mg from Ernest Oncology?

• Expert Indian Exporter: Direct access to India's world-class generic manufacturing hub.

• Wholesale Pricing: Competitive rates for bulk institutional orders.

• Global Logistics: Expertise in shipping to major trade hubs like the USA, UK, UAE, Australia, and South Africa.

• Authenticity: Guaranteed genuine products with complete certification.

Administration and Safety Protocols

• Dosage: For RCC and GIST, the typical regimen is 50 mg once daily for 4 weeks, followed by a 2-week "off" period. Always follow the oncologist's specific prescription

• Storage: Store at room temperature (20°C to 25°C) in a dry place.

• Monitoring: Patients should be monitored for hypertension, fatigue, and thyroid function during the treatment cycle.